Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VIRTUOSE : Efficiency of Sildenafil on the Absolute Claudication Distance of Peripheral Arterial Disease Patients With Intermittent Claudication. A Phase III, National, Multicentre, Prospective, Randomised, Double-blind, Placebo-Controlled Trial.

NCT03686306 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.

NCT NCT03686306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03686306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VIRTUOSE : Efficiency of Sildenafil on the Absolute Claudication Distance of Peripheral Arterial Disease Patients With Intermittent Claudication. A Phase III, National, Multicentre, Prospective, Randomised, Double-blind, Placebo-Controlled Trial.
Lead sponsor
Rennes University Hospital
Phase
Phase 3
Overall status
Active, not recruiting
Start date
November 24, 2021
Completion date
June 24, 2026
Enrollment
106 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral artery disease